Norepinephrine turnover in peripheral tissues of rats with heart failure

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 278, Issue 3 47-3, 2000, Pages

  Patel, Kaushik P ^a,b   Zhang, Kun ^a   Carmines, Pamela K ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Myocardial infarction; Renal nerve activity; Sympathetic activation

Indexed keywords

NORADRENALIN; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GANGLION BLOCK; HEART; HEART FAILURE; HEART INFARCTION; HISTOLOGY; KIDNEY; KIDNEY NERVE; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; SYMPATHETIC TONE;

EID: 0034016799     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.2000.278.3.r556     Document Type: Article

References (43)

1. Akama, H., B. P. McGrath, and E. Badoer. Volume expansion fails to normally activate neural pathways in the brain of conscious rabbits with heart failure. J. Auton. Nerv. Syst. 73: 54-62, 1998.
2. Badoer, E., V. Moguilevski, and B. P. McGrath. Cardiac afferents play the dominant role in renal nerve inhibition elicited by volume expansion in the rabbit. Am. J. Physiol. Regulatory Integrative Comp. Physiol. 274: R383-R388, 1998.
3. Brändle, M., K. P. Patel, W. Wang, and I. H. Zucker. Hemodynamic and norepinephrine responses to pacing-induced heart failure in conscious sinoaortic-denervated dogs. J. Appl. Physiol. 81: 1855-1862, 1996.
4. Bristow, M. R., R. Ginsburg, W. Minobe, R. S. Cubicciotti, W. S. Sageman, K. Lurie, M. E. Billingham, D. C. Harrison, and E. B. Stinson. Decreased catecholamine sensitivity and β-adrenergic receptor density in failing human hearts. N. Engl. J. Med. 307: 205-211, 1982.
5. Brodie, B. B., E. Costa, A. Dlabac, N. H. Neff, and H. H. Smookler. Application of steady state kinetics to the estimations of synthesis rate and turnover time of tissue catecholamines. J. Pharmacol. Exp. Ther. 154: 493-498, 1966.
6. Chidsey, C. A., and E. Braunwald. Sympathetic activity and neurotransmitter depletion in congestive heart failure. Pharmacol. Rev. 18: 685-700, 1966.
7. Clemson, B., L. Gaul, S. S. Gubin, D. M. Campsey, J. McConville, J. Nussberger, and R. Zelis. Prejunctional angiotensin II receptors. Facilitation of norepinephrine release in the human forearm. J. Clin. Invest. 93: 684-691, 1994.
8. Cohn, J. N., T. B. Levine, M. T. Olivari, V. Garberg, D. Lura, G. S. Francis, A. B. Simon, and T. Rector. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N. Engl. J. Med. 311: 819-823, 1984.
9. Covell, J. W., C. A. Chidsey, and E. Braunwald. Reduction of the cardiac response to postganglionic sympathetic nerve stimulation in experimental heart failure. Circ. Res. 19: 51-56, 1966.
10. DiBona, G. F., S. Y. Jones, and V. L. Brooks. ANG II receptor blockade and arterial baroreflex regulation of renal nerve activity in cardiac failure. Am. J. Physiol. Regulatory Integrative Comp. Physiol. 269: R1189-R1196, 1995.
11. DiBona, G. F., and U. C. Kopp. Neural control of renal function. Physiol. Rev. 77: 75-197, 1997.
12. 2 in guinea-pig vas deferens. Naunyn Schmiedebergs Arch. Pharmacol. 350: 618-625, 1994.
13. Eisenhofer, G., P. Friberg, B. Rundqvist, A. A. Quyyumi, G. Lambert, D. M. Kaye, I. J. Kopin, D. S. Goldstein, and M. D. Esler. Cardiac sympathetic nerve function in congestive heart failure. Circulation 93: 1667-1676, 1996.
14. Esler, M., G. Jennings, G. Lambert, I. Meredith, M. Home, and G. Eisenhofer. Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions. Physiol. Rev. 70: 963-985, 1990.
15. Feng, Q. P., S. Carlsson, P. Thoren, and T. Hedner. Characteristics of renal sympathetic nerve activity in experimental congestive heart failure in the rat. Acta Physiol. Scand. 150: 259-266, 1994.
16. Ferguson, D. W., W. J. Berg, and J. S. Sanders. Clinical and hemodynamic correlates of sympathetic nerve activity in normal humans and patients with heart failure: evidence from direct microneurographic recordings. J. Am. Coll. Cardiol. 16: 1125-1134, 1990.
17. Fischer, J. E., W. D. Horst, and I. J. Kopin. Norepinephrine metabolism in hypertrophied rat hearts. Nature 207: 951-953, 1965.
18. Fishbein, M. C., D. Maclean, and P. R. Maroko. Experimental myocardial infarction in the rat. Qualitative and quantitative changes during pathologic evolution. Am. J. Pathol. 90: 57-70, 1978.
19. Ganguly, P. K., K. S. Dhalla, I. R. Innes, R. E. Beamish, and N. S. Dhalla. Altered norepinephrine turnover and metabolism in diabetic cardiomyopathy. Circ. Res. 59: 684-693, 1986.
20. Goldstein, A. Biostatistics: An Introductory Text. New York: Macmillan, 1964.
21. Gottschalk, C. W. Renal nerve and sodium excretion. Annu. Rev. Physiol. 41: 229-240, 1979.
22. Hasking, G. J., M. D. Esler, G. L. Jennings, D. Burton, and P. I. Korner. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardio-renal sympathetic nervous activity. Circulation 73: 615-621, 1986.
23. Hopp, F. A., J. L. Seagard, and J. P. Kampine. Comparison of four methods of averaging nerve activity. Am. J. Physiol. Regulatory Integrative Comp. Physiol. 251: R700-R711, 1986.
24. Kirchheim, H. R. Systemic arterial baroreceptor reflexes. Physiol. Rev. 56: 100-176, 1976.
25. Kon, V., A. Yared, and I. Ichikawa. Role of renal sympathetic nerves in mediating hypoperfusion of renal cortical microcirculation in experimental congestive HF and acute extracellular fluid volume depletion. J. Clin. Invest. 76: 1913-1920, 1985.
26. Lambert, G. W., D. M. Kaye, J. Lefkovits, G. L. Jennings, A. G. Turner, H. S. Cox, and M. D. Esler. Increased central nervous system monoamine neurotransmitter turnover and its association with sympathetic nervous activity in treated heart failure patients. Circulation 92: 1813-1818, 1995.
27. Leenen, F. H. H., B. S. Huang, H. L. Yu, and B. X. Yuan. Brain "ouabain" mediates sympathetic hyperactivity in congestive heart failure. Circ. Res. 77: 993-1000, 1995.
28. Leimbach, W. N., B. Gunner Wallin, R. G. Victor, P. E. Aylward, G. Sundlof, and A. L. Mark. Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure. Circulation 73: 913-919, 1986.
29. Meredith, I. T., G. Eisenhofer, G. W. Lambert, E. M. Dewar, G. L. Jennings, and M. D. Esler. Cardiac sympathetic nervous activity in congestive heart failure: evidence for increased neuronal norepinephrine release and preserved neuronal uptake. Circulation 88: 136-145, 1993.
30. Patel, K. P. Neural regulation in experimental heart failure. Bailliere's Clin. Neurol 6: 283-296, 1997.
31. Patel, K. P., J. Ciriello, and R. L. Kline. Noradrenergic mechanisms in brain and peripheral organs after aortic nerve transection. Am. J. Physiol. Heart Circ. Physiol. 240: H481-H486, 1981.
32. Patel, K. P., and K. Zhang. Neurohumoral activation in heart failure: role of paraventricular nucleus. Clin. Exp. Pharmacol. Physiol. 23: 722-726, 1996.
33. Patel, K. P., K. Zhang, I. H. Zucker, and T. L. Krukoff. Decreased gene expression of neuronal nitric oxide synthase in hypothalamus and brainstem of rats in heart failure. Brain Res. 734: 109-115, 1996.
34. Patel, K. P., P. L. Zhang, and P. K. Carmines. Neural influences on renal responses to acute volume expansion in rats with heart failure. Am. J. Physiol. Heart Circ. Physiol. 271: H1441-H1448, 1996.
35. Patel, K. P., P. L. Zhang, and T. L. Krukoff. Alterations in brain hexokinase activity associated with heart failure in rats. Am. J. Physiol. Regulatory Integrative Comp. Physiol. 265: R923-R928, 1993.
36. Pfeffer, M. A., J. M. Pfeffer, M. C. Fishbein, P. J. Fletcher, J. Spadaro, R. A. Kloner, and E. Braunwald. Myocardial infarct size and ventricular function in rats. Circ. Res. 44: 503-512, 1979.
37. Pool, P. E., J. W. Covell, M. Levitt, J. Gibb, and E. Braunwald. Reduction of cardiac tyrosine hydroxylase activity in experimental congestive heart failure. Circ. Res. 20: 349-353, 1967.
38. Rundqvist, B., M. Elam, Y. Bergmann-Sverrisdottir, G. Eisenhofer, and P. Friberg. Increased cardiac adrenergic drive precedes generalized sympathetic activation in human heart failure. Circulation 95: 169-175, 1997.
39. Sharman, D. F. The turnover of catecholamines. In: Central Neurotransmitter Turnover, edited by C. J. Pycock and P. V. Taberner. London: Oxford, 1981, p. 20-58.
40. Sole, M. J., M. N. Hussain, D. H. G. Versteeg, E. R Ronald de Kloet, D. Adams, and W. Lixfeld. The identification of specific brain nuclei in which catecholamine turnover is increased by left ventricular receptors during acute myocardial ischemia in the rat. Brain Res. 235: 315-325, 1982.
41. Sole, M. J., C.-M. Lo, C. W. Laird, E. H. Sonnenblick, and R. J. Wurtman. Norepinephrine turnover in the heart and spleen of the cardiomyopathic Syrian hamster. Circ. Res. 37: 855-862, 1975.
42. Vahid-Ansari, F., and F. H. H. Leenen. Pattern of neuronal activation in rats with CHF after myocardial infarction. Am. J. Physiol. Heart Circ. Physiol. 275: H2140-H2146, 1998.
43. Zucker, I. H., W. Wang, M. Brändle, H. D. Schultz, and K. P. Patel. Neural regulation of sympathetic nerve activity in heart failure. Prog. Cardiovasc. Dis. 37: 397-414, 1995.